Bioinformatics analysis revealed that gene expression sets of Regnase-1-deleted mouse HSPCs were significantly enriched in the group of human AMLs tested, but gene mutations and mRNA alterations of Regnase-1 in human AML patients had not been reported thus far. Here, ZC3H12A is linked to acute myeloid leukemia.